ELAPRASE (idursulfase) injection. FDA Approved
ELAPRASE (idursulfase) injection
INDICATIONS AND USAGE
ELAPRASE is a hydrolytic lysosomal glycosaminoglycan (GAG)-specific enzyme indicated for patients with Hunter syndrome (Mucopolysaccharidosis II, MPS II).
ELAPRASE has been shown to improve walking capacity in patients 5 years and older. In patients 16 months to 5 years of age, no data are available to demonstrate improvement in disease-related symptoms or long term clinical outcome; however, treatment with ELAPRASE has reduced spleen volume similarly to that of adults and children 5 years of age and older. The safety and efficacy of ELAPRASE have not been established in pediatric patients less than 16 months of age .
DOSAGE FORMS & STRENGTHS: Injection: 6 mg/3 mL (2 mg/mL) in single-use vial
Manufactured By: Shire Medical Information
Prescribing Information URL: Click Here
HOW TO MAKE AN ENQUIRY FOR ELAPRASE (idursulfase) injection?
FDA approved Anti-Cancer medicine ELAPRASE (idursulfase) injection is available upon request. To get best retail price of ELAPRASE (idursulfase) injection in India, For emergency product orders call 8750295029 (Mr. Neeraj Nagpal) or For enquires email email@example.com For advanced treatments in India, Medvitaz Pharma Solution can even help patient to discuss with ophthalmologist.